Fund Holdings — BVF INC/IL

Total Portfolio Value:
$3.42B
Total Bought:
$61.61M
Total Sold:
$464.38M
Net Transaction:
-$402.77M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)21,751,28421,751,2840$956.40M$1.10B32.08%+$140.30M
Kymera Therapeutics, Inc.(KYMR)5,161,8015,161,8010$154.08M$244.31M7.15%+$90.23M
Revolution Medicines, Inc.(RVMD)5,981,2123,478,612-2,502,600$232.13M$157.76M4.61%-$74.38M
Mirum Pharmaceuticals, Inc.(MIRM)4,370,0243,075,907-1,294,117$149.41M$119.96M3.51%-$29.45M
Tyra Biosciences, Inc.(TYRA)4,661,1944,661,1940$74.53M$109.58M3.21%+$35.05M
Olema Pharmaceuticals, Inc.(OLMA)9,135,8939,135,8930$98.85M$109.08M3.19%+$10.23M
Structure Therapeutics IncADS2,487,7622,238,986-248,776$97.69M$98.27M2.87%+$574.7K
Cullinan Therapeutics, Inc.(CGEM)5,750,6835,750,6830$100.29M$96.27M2.82%-$4.03M
Xoma Royalty Corporation3,633,7433,633,7430$86.08M$96.22M2.81%+$10.14M
Axsome Therapeutics, Inc.(AXSM)955,0001,046,000+91,000$76.88M$94.00M2.75%+$17.13M
Protagonist Therapeutics Inc3,319,2901,850,167-1,469,123$115.01M$83.26M2.44%-$31.76M
4d Molecular Therapeutics In3,922,4137,382,642+3,460,229$82.33M$79.81M2.33%-$2.53M
AC Immune SASHS(ACIU)18,834,93619,522,436+687,500$75.15M$73.79M2.16%-$1.36M
GH Research PLC(GHRS)10,400,15810,400,1580$121.27M$69.58M2.04%-$51.69M
Kura Oncology, Inc.(KURA)4,082,0373,371,761-710,276$84.05M$65.88M1.93%-$18.16M
Third Harmonic Bio Inc4,365,9334,365,9330$56.76M$59.16M1.73%+$2.40M
Ionis Pharmaceuticals, Inc.(IONS)3,186,3761,451,879-1,734,497$151.86M$58.16M1.70%-$93.70M
Zymeworks Inc.(ZYME)5,870,0004,607,935-1,262,065$49.95M$57.83M1.69%+$7.88M
Essa Pharma Inc8,748,6298,748,6290$46.02M$53.02M1.55%+$7.00M
Agios Pharmaceuticals, Inc.(AGIO)1,190,1071,190,1070$51.32M$52.88M1.55%+$1.56M
Celcuity Inc.(CELC)3,466,0003,466,0000$56.77M$51.68M1.51%-$5.10M
89bio Inc7,568,4796,811,631-756,848$60.62M$50.41M1.47%-$10.22M
Foghorn Therapeutics Inc.(FHTX)5,302,0005,302,0000$30.49M$49.36M1.44%+$18.88M
Lakefront Biotherapeutics NVADR(LKFT)1,569,4221,569,4220$38.89M$45.18M1.32%+$6.29M
IDEAYA Biosciences, Inc.(IDYA)1,162,3061,409,993+247,687$40.81M$44.67M1.31%+$3.86M
Annexon, Inc.(ANNX)7,000,0007,000,0000$34.30M$41.44M1.21%+$7.14M
CG Oncology, Inc.(CGON)2,417,885994,596-1,423,289$76.33M$37.53M1.10%-$38.81M
Repare Therapeutics Inc10,333,60010,333,6000$34.10M$35.55M1.04%+$1.45M
Newamsterdam Pharma Company
ORDINARY SHARES
1,521,9481,521,9480$29.24M$25.26M0.74%-$3.97M
Xencor, Inc.(XNCR)0850,000+850,000$0$17.09M0.50%+$17.09M
Eledon Pharmaceuticals, Inc.(ELDN)6,293,2826,293,2820$16.61M$15.67M0.46%-$944.0K
TScan Therapeutics, Inc.(TCRX)2,989,4742,989,4740$17.49M$14.89M0.44%-$2.60M
Engene Holdings Inc
COM
2,251,0372,251,0370$21.23M$14.86M0.43%-$6.37M
Immunic, Inc.(IMUX)8,902,9728,902,9720$9.88M$14.69M0.43%+$4.81M
Allakos Inc16,552,41716,552,4170$16.55M$10.81M0.32%-$5.74M
Avalo Therapeutics, Inc.(AVTX)0967,000+967,000$0$9.15M0.27%+$9.15M
Ikena Oncology Inc4,769,1644,769,1640$7.87M$8.25M0.24%+$381.5K
Cidara Therapeutics Inc343,055703,065+360,010$4.10M$7.56M0.22%+$3.46M
CytomX Therapeutics, Inc.(CTMX)5,228,4615,228,4610$6.38M$6.17M0.18%-$209.1K
Vigil Neuroscience Inc1,813,6331,813,6330$7.25M$6.17M0.18%-$1.09M
Vistagen Therapeutics, Inc.(VTGN)2,000,0002,000,0000$6.96M$6.02M0.18%-$940.0K
Verastem, Inc.(VSTM)1,685,2191,685,2190$5.02M$5.04M0.15%+$16.9K
Ovid Therapeutics Inc.(OVID)3,853,8183,853,8180$2.96M$4.55M0.13%+$1.58M
Pieris Pharmaceuticals Inc257,626257,6260$2.55M$4.31M0.13%+$1.77M
Verve Therapeutics Inc650,000650,0000$3.17M$3.15M0.09%-$26.0K
SAB Biotherapeutics, Inc.(SABS)917,826917,8260$2.85M$2.48M0.07%-$367.1K
Molecular Partners AGADS(MOLN)443,221443,2210$3.17M$2.14M0.06%-$1.03M
Elevation Oncology Inc2,312,2002,966,836+654,636$6.24M$1.78M0.05%-$4.46M
Glycomimetics Inc9,544,2629,544,2620$2.69M$1.61M0.05%-$1.07M
Inventiva S.A.ADS(IVA)686,040686,0400$2.02M$1.27M0.04%-$754.6K
Tenax Therapeutics, Inc.(TENX)0339,549+339,549$0$1.17M0.03%+$1.17M
Engene Holdings IncW EXP 10 31 202
*W EXP 10/31/202
945,402945,4020$1.31M$803.7K0.02%-$510.4K
Molecular Templates Inc522,238522,2380$600.6K$733.7K0.02%+$133.2K
Nls Pharmaceutics Ltd0143,676+143,676$0$728.4K0.02%+$728.4K
Forte Biosciences Inc0119,282+119,282$0$668.0K0.02%+$668.0K
Aslan Pharmaceuticals LtdADS1,049,9990-1,049,999$315.0K$0—-$315.0K
Calliditas Therapeutics AbADS750,0000-750,000$29.24M$0—-$29.24M
Forte Biosciences Inc2,982,1050-2,982,105$1.60M$0—-$1.60M
Janux Therapeutics, Inc.(JANX)441,5280-441,528$18.50M$0—-$18.50M
Merus N V1,279,0490-1,279,049$75.68M$0—-$75.68M
Nls Pharmaceutics LtdSHS5,747,1260-5,747,126$1.25M$0—-$1.25M
Rezolute, Inc.(RZLT)190,8150-190,815$820.5K$0—-$820.5K
Roivant Sciences Ltd.SHS(ROIV)2,742,4090-2,742,409$28.99M$0—-$28.99M
Unicycive Therapeutics Inc2,200,0000-2,200,000$1.10M$0—-$1.10M
Viracta Therapeutics Inc3,614,6620-3,614,662$1.97M$0—-$1.97M
Page 1 of 1
BVF INC/IL — 13F Holdings — Q3 2024 | TickerTrail